| Bioactivity | Erlotinib lactam impurity (compound 7a) is a precursor of the tyrosine kinase inhibitor[1]. | ||||||||||||
| CAS | 179688-29-0 | ||||||||||||
| Formula | C14H18N2O5 | ||||||||||||
| Molar Mass | 294.30 | ||||||||||||
| Appearance | 固体 | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Yann Seimbille, et al. Fluorine-18 labeling of 6,7-disubstituted anilinoquinazoline derivatives for positron emission tomography (PET) imaging of tyrosine kinase receptors: synthesis of 18F-Iressa and related molecular probes. J Label Compd Radiopharm 2005; 48: 829–843. |